Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Imodium SoftGels 2mg capsules
0104020L0BBANAA
|
Imodium | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Imuldosa 130mg/26ml concentrate for inf vials
0105030B0BHAAAA
|
Imuldosa | Ustekinumab | Gastro-Intestinal System | No data available |
|
Indian Brandee oral liquid
010102100BBBEA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Indigestion mixture
010101000BBAJA0
|
Proprietary compound preparation BNF 0101010 | Other antacid and simeticone preparations | Gastro-Intestinal System | No data available |
|
Ipocol 400mg gastro-resistant tablets
0105010B0BFAAAA
|
Ipocol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Iqirvo 80mg tablets
0109010W0BBAAAA
|
Iqirvo | Elafibranor | Gastro-Intestinal System | No data available |
|
Isogel 90% granules
0106010E0BCAAAC
|
Isogel | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 3.4g oral pdr sachets gluten free sugar free
0106010E0AAAJAJ
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 3.5g oral pdr sachets gluten free sugar free
0106010E0AAASAS
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 6g oral powder sachets gluten free sugar free
0106010E0AAAKAK
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 90% granules for oral suspension sugar free
0106010E0AAACAC
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk oral powder sugar free
0106010E0AAAVAV
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Izinova concentrate for oral solution
0106050B0BGAAA0
|
Izinova | Bowel cleansing solutions | Gastro-Intestinal System | No data available |
|
J Collis Browne's tablets
0104020N0BEABAF
|
J Collis Browne's | Opium and morphine | Gastro-Intestinal System | No data available |
|
Kao-C junior diarrhoea oral suspension
0104010H0BEAAAL
|
Kao-C | Kaolin light | Gastro-Intestinal System | No data available |
|
Kaodene oral suspension
0104020D0BBAAAB
|
Kaodene | Codeine phosphate compound mixtures | Gastro-Intestinal System | No data available |
|
Kaolin 400mg / Calcium carbonate 75mg tablets
0104010H0AAAKAK
|
Kaolin light | Kaolin light | Gastro-Intestinal System | No data available |
|
Kaolin 500mg/5ml / Calcium carbonate 250mg/5ml susp SF
0104010H0AAALAL
|
Kaolin light | Kaolin light | Gastro-Intestinal System | No data available |
|
Kaolin light 1.5g/5ml / Codeine 5mg/5ml susp sugar free
0104020D0AAABAB
|
Codeine phosphate (Compound preparations) | Codeine phosphate compound mixtures | Gastro-Intestinal System | No data available |
|
Kaolin mixture
0104010H0AAABAB
|
Kaolin light | Kaolin light | Gastro-Intestinal System | No data available |
|
Kaolin mixture paediatric
0104010H0AAACAC
|
Kaolin light | Kaolin light | Gastro-Intestinal System | No data available |
|
Kolbam 250mg capsules
0109010H0BCABAE
|
Kolbam | Cholic acid | Gastro-Intestinal System | No data available |
|
Kolbam 50mg capsules
0109010H0BCAAAI
|
Kolbam | Cholic acid | Gastro-Intestinal System | No data available |
|
Konsyl 6g oral powder sachets
0106010E0BHAAAK
|
Konsyl | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Konsyl Orange Sugar Free 3.5g oral powder sachets
0106010E0BHADAS
|
Konsyl | Ispaghula husk | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.